These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 35967323)

  • 1. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
    Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
    Front Immunol; 2021; 12():641360. PubMed ID: 34054808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
    Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
    Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
    Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
    Front Immunol; 2018; 9():1586. PubMed ID: 30105014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.
    Beirag N; Varghese PM; Neto MM; Al Aiyan A; Khan HA; Qablan M; Shamji MH; Sim RB; Temperton N; Kishore U
    Viruses; 2023 May; 15(6):. PubMed ID: 37376569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells.
    Johnson EL; Ohkawa Y; Kanto N; Fujinawa R; Kuribara T; Miyoshi E; Taniguchi N
    Cell Stress Chaperones; 2024 Apr; 29(2):227-234. PubMed ID: 38453000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
    Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
    J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
    Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
    Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
    Thépaut M; Luczkowiak J; Vivès C; Labiod N; Bally I; Lasala F; Grimoire Y; Fenel D; Sattin S; Thielens N; Schoehn G; Bernardi A; Delgado R; Fieschi F
    PLoS Pathog; 2021 May; 17(5):e1009576. PubMed ID: 34015061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Protein Interaction between Surfactant Protein D and DC-SIGN
    Dodagatta-Marri E; Mitchell DA; Pandit H; Sonawani A; Murugaiah V; Idicula-Thomas S; Nal B; Al-Mozaini MM; Kaur A; Madan T; Kishore U
    Front Immunol; 2017; 8():834. PubMed ID: 28824609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein D inhibits mite-induced alveolar macrophage and dendritic cell activations through TLR signalling and DC-SIGN expression.
    Liu CF; Rivere M; Huang HJ; Puzo G; Wang JY
    Clin Exp Allergy; 2010 Jan; 40(1):111-22. PubMed ID: 20205699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection.
    Tang L; Ding H; Zeng Q; Zhou R; Liu B; Huang X
    ACS Biomater Sci Eng; 2023 Dec; 9(12):6783-6796. PubMed ID: 37969099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
    Cai G; Du M; Bossé Y; Albrecht H; Qin F; Luo X; Androulakis XM; Cheng C; Nagarkatti M; Nagarkatti P; Christiani DC; Whitfield ML; Amos CI; Xiao F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
    Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
    Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
    Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
    Lu Q; Liu J; Zhao S; Gomez Castro MF; Laurent-Rolle M; Dong J; Ran X; Damani-Yokota P; Tang H; Karakousi T; Son J; Kaczmarek ME; Zhang Z; Yeung ST; McCune BT; Chen RE; Tang F; Ren X; Chen X; Hsu JCC; Teplova M; Huang B; Deng H; Long Z; Mudianto T; Jin S; Lin P; Du J; Zang R; Su TT; Herrera A; Zhou M; Yan R; Cui J; Zhu J; Zhou Q; Wang T; Ma J; Koralov SB; Zhang Z; Aifantis I; Segal LN; Diamond MS; Khanna KM; Stapleford KA; Cresswell P; Liu Y; Ding S; Xie Q; Wang J
    Immunity; 2021 Jun; 54(6):1304-1319.e9. PubMed ID: 34048708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
    Lempp FA; Soriaga LB; Montiel-Ruiz M; Benigni F; Noack J; Park YJ; Bianchi S; Walls AC; Bowen JE; Zhou J; Kaiser H; Joshi A; Agostini M; Meury M; Dellota E; Jaconi S; Cameroni E; Martinez-Picado J; Vergara-Alert J; Izquierdo-Useros N; Virgin HW; Lanzavecchia A; Veesler D; Purcell LA; Telenti A; Corti D
    Nature; 2021 Oct; 598(7880):342-347. PubMed ID: 34464958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.